BRITTANY DEHAVEN: Open Payments
NPI 1629675293 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 63 payments from 12 companies in 2025. Trend: 2023 $1,849 · 2024 $1,620 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $319 |
| Novo Nordisk Inc | 7 | $182 |
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| PFIZER INC. | 13 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Medtronic, Inc. | 2 | $78 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Lilly USA, LLC | 3 | $64 |
| Exact Sciences Corporation | 2 | $61 |
| Amgen Inc. | 3 | $55 |
Products named: VRAYLAR, QULIPTA, PREVNAR 20, Kerendia, MINIMED 780G, ELIQUIS, FARXIGA, GARDASIL 9.
Industry payments across VA — which companies pay providers there.
